Oxford Immunotec
Business Services · United Kingdom · 201-500 Employees
View Company Info for Free
Overview
Headquarters
143 Park Drive Milton Park, Abingdon, Ox...Phone Number
+44 1235442780Website
www.oxfordimmunotec.comRevenue
$73.7 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
2
1
1
1
1
About Oxford Immunotec
Established in 2002, Oxford Immunotec is a commercial-stage diagnostics company focused on developing and commercializing proprietary tests for the management of immune-regulated conditions. They are headquartered near Oxford, UK.Explore more
Oxford Immunotec Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Oxford Immunotec your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Oxford Immunotec launches new products
Congratulate Masked Content for being promoted to Masked Content at Oxford Immunotec
Check if Oxford Immunotec has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Check out if Oxford Immunotec is spiking on competitors!
Click to see if Oxford Immunotec had a recent Job posting/layoffs
Oxford Immunotec, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Oxford Immunotec has new funding data
Earning: See what the market has to say on Oxford Immunotec recently announced quarterly report
Recommended Actions
Find VP level buyers at Oxford Immunotec
Find 2 more new buyers
Compare Similar Companies to Oxford Immunotec
Compare insights from companies similar to Oxford Immunotec, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Oxford Immunotec is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Oxford Immunotec is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Oxford Immunotec.
Oxford Immunotec financials insights
Gather financial insights about Oxford Immunotec, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2005
Series B
$8.7M
2007
Series C
$40M
2010
Series D
$26M
2012
Series E
$28M
2013
Stock Offering
$62.8M
2016
Debt
$40M
2017
Stock Offering
$40.1M
Oxford Immunotec Tech Stack
A closer look at the technologies used by Oxford Immunotec
See more technologies
Most Recent Scoops
Open Position
Event
will be attending the Medlab Middle East 2023 conference as an exhibitor. The event will occur from February 6 to February 9, 2023.
Event
will be attending the 2022 AACC Annual Scientific Meeting + Clinical Lab Expo conference as an exhibitor. The event will occur from July 24 to July 28, 2022.
Lateral Move
Executive Move
Promotion
Executive Move
Oxford Immunotec News & Media
Oxford Immunotec’s T-SPOT Discovery SARS-CoV-2 Test Used in DIRECT Study to Investigate the T Cell Response and COVID Vaccination in Ethnic Minority Groups
OXFORD, United Kingdom and MARLBOROUGH, Mass., April 29, 2021 (GLOBE NEWSWIRE) -- Oxford Immunotec a global, high-growth diagnostics company part of PerkinElmer (NYSE: PKI), today announced that its T-SPOT® Discovery SARS-CoV-2 kit will be used for T cell testing in the DIRECT study. Oxford Immunotec is collaborating with researchers at the University of Leicester on DIRECT (Determining the Immune Response in Ethnic minority healthcare workers to COVID-19 infection). The study, funded through thOxford Immunotec’s T-SPOT Discovery SARS-CoV-2 Test is Used in UK Com-COV Clinical Trial to Investigate the T Cell Response in Different Combinations of Approved COVID-19 Vaccines for the First and Second Doses
OXFORD, United Kingdom and MARLBOROUGH, Mass., April 27, 2021 (GLOBE NEWSWIRE) -- Oxford Immunotec, a global, high-growth diagnostics company part of PerkinElmer (NYSE: PKI), today announced that its T-SPOT® Discovery SARS-CoV-2 kit will be used for T cell testing in the UK Com-COV trial. The company is collaborating with the Oxford Vaccine Group, part of the team that developed the Oxford-AstraZeneca vaccine, who is leading the Com-COV trial. The trial will help understanding of thePerkinElmer Completes Acquisition of Oxford Immunotec Global PLC
WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc., (NYSE: PKI) a global leader committed to innovating for a healthier world, today announced that the Company has completed its previously announced acquisition of Oxford Immunotec Global PLC (Oxford Immunotec). PerkinElmer originally announced its intent to acquire Oxford Immunotec on January 7, 2021. “Oxford Immunotec’s global role in fighting tuberculosis, particularly its trademark product, the T-SPOT®.TB test, and the operations it has builOxford Immunotec Submits Emergency Use Authorization Request to the FDA and CE Marks T-SPOT®.COVID, a Test for the Detection of a Cell Mediated (T cell) Immune Response to SARS-CoV-2 Infection
OXFORD, United Kingdom and MARLBOROUGH, Mass., March 4, 2021 /PRNewswire/ -- Oxford Immunotec Global PLC (Nasdaq: OXFD) (the "Company"), a global, high-growth diagnostics company, announced that today it has released the T-SPOT.COVID test, a CE marked ELISPOT based test intended for...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Oxford Immunotec
Sign Up For FreeTo access detailed company insights
Established in 2002, Oxford Immunotec is a commercial-stage diagnostics company focused on developing and commercializing proprietary tests for the management of immune-regulated conditions. They are headquartered near Oxford, UK.... Read More
